ProShares - Ultra Nasdaq Biotechnology (BIB) Research
The ProShares Ultra Nasdaq Biotechnology fund is structured to provide daily investment returns that effectively magnify the daily performance of the Nasdaq Biotechnology Index by two hundred percent (2x), all measured before accounting for any associated fees and expenses.
Market snapshot
- Symbol
- BIB
- Price
- $85.02
- Day change
- +0.09%
- Market cap
- $74.0M
- 52-week range
- 44.2-90.91
- Sector
- Financial Services
- Industry
- Asset Management - Leveraged
Peer companies
- BNY Mellon US Small Cap Core Equity ETF (BKSE)
- Cambiar Aggressive Value ETF (CAMX)
- Madison Dividend Value ETF (DIVL)
- Unusual Whales Subversive Republican Trading ETF (GOP)
- iShares LifePath Target Date 2035 ETF (ITDC)
- Impact Shares NAACP Minority Empowerment ETF (NACP)
- Rareview Systematic Equity ETF (RSEE)
- MRP SynthEquity ETF (SNTH)
Open ProShares - Ultra Nasdaq Biotechnology (BIB) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.